FGFR3 and urinary bladder neoplasm: We have identified a novel FGFR3‐MYC positive feedback loop in bladder tumor cell lines harboring aberrantly activated FGFR3, which may be of clinical relevance, because it was also found in a PDX model harboring an FGFR3 mutation.